These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 23283721)

  • 1. Circulating microRNAs as novel biomarkers for platelet activation.
    Willeit P; Zampetaki A; Dudek K; Kaudewitz D; King A; Kirkby NS; Crosby-Nwaobi R; Prokopi M; Drozdov I; Langley SR; Sivaprasad S; Markus HS; Mitchell JA; Warner TD; Kiechl S; Mayr M
    Circ Res; 2013 Feb; 112(4):595-600. PubMed ID: 23283721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels.
    Parker WAE; Schulte C; Barwari T; Phoenix F; Pearson SM; Mayr M; Grant PJ; Storey RF; Ajjan RA
    Cardiovasc Diabetol; 2020 Jan; 19(1):3. PubMed ID: 31910903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MicroRNAs and YRNAs With Platelet Function.
    Kaudewitz D; Skroblin P; Bender LH; Barwari T; Willeit P; Pechlaner R; Sunderland NP; Willeit K; Morton AC; Armstrong PC; Chan MV; Lu R; Yin X; Gracio F; Dudek K; Langley SR; Zampetaki A; de Rinaldis E; Ye S; Warner TD; Saxena A; Kiechl S; Storey RF; Mayr M
    Circ Res; 2016 Feb; 118(3):420-432. PubMed ID: 26646931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report.
    Chyrchel B; Totoń-Żurańska J; Kruszelnicka O; Chyrchel M; Mielecki W; Kołton-Wróż M; Wołkow P; Surdacki A
    Platelets; 2015; 26(6):593-7. PubMed ID: 25350775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y
    Braza-Boïls A; Barwari T; Gutmann C; Thomas MR; Judge HM; Joshi A; Pechlaner R; Shankar-Hari M; Ajjan RA; Sabroe I; Storey RF; Mayr M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet MicroRNA 365-3p Expression Correlates with High On-treatment Platelet Reactivity in Coronary Artery Disease Patients.
    Chen YC; Lin FY; Lin YW; Cheng SM; Chang CC; Lin RH; Chuang CL; Sheu JS; Chen SM; Tsai CS
    Cardiovasc Drugs Ther; 2019 Apr; 33(2):129-137. PubMed ID: 30783954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite.
    Sugidachi A; Ogawa T; Kurihara A; Hagihara K; Jakubowski JA; Hashimoto M; Niitsu Y; Asai F
    J Thromb Haemost; 2007 Jul; 5(7):1545-51. PubMed ID: 17456192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoring.
    Krammer TL; Mayr M; Hackl M
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial.
    Angiolillo DJ; Badimon JJ; Saucedo JF; Frelinger AL; Michelson AD; Jakubowski JA; Zhu B; Ojeh CK; Baker BA; Effron MB
    Eur Heart J; 2011 Apr; 32(7):838-46. PubMed ID: 21252171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease.
    Darlington A; Tello-Montoliu A; Rollini F; Ueno M; Ferreiro JL; Patel R; Desai B; Guzman LA; Bass TA; Angiolillo DJ
    Thromb Haemost; 2014 Feb; 111(2):258-65. PubMed ID: 24154863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation.
    Zafar MU; Santos-Gallego C; Vorchheimer DA; Viles-Gonzalez JF; Elmariah S; Giannarelli C; Sartori S; Small DS; Jakubowski JA; Fuster V; Badimon JJ
    J Thromb Haemost; 2013 Jan; 11(1):100-6. PubMed ID: 23137352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course of platelet miRNAs after cessation of P2Y12 antagonists.
    Jäger B; Stojkovic S; Haller PM; Piackova E; Kahl BS; Andric T; Vargas KG; Wojta J; Huber K
    Eur J Clin Invest; 2019 Aug; 49(8):e13149. PubMed ID: 31172515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial.
    Small DS; Payne CD; Kothare P; Yuen E; Natanegara F; Teng Loh M; Jakubowski JA; Richard Lachno D; Li YG; Winters KJ; Farid NA; Ni L; Salazar DE; Tomlin M; Kelly R
    Clin Ther; 2010 Feb; 32(2):365-79. PubMed ID: 20206794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
    Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets.
    Scharbert G; Wetzel L; Schrottmaier WC; Kral JB; Weber T; Assinger A
    Transfusion; 2015 Jun; 55(6):1320-6. PubMed ID: 25641006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microRNAs characterising patients with immune thrombocytopenic purpura.
    Zuo B; Zhai J; You L; Zhao Y; Yang J; Weng Z; Dai L; Wu Q; Ruan C; He Y
    Thromb Haemost; 2017 Jun; 117(7):1420-1431. PubMed ID: 28424819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet microRNAs: Novy Mir* or mired in human complexity?
    Curtis AM; FitzGerald GA
    Circ Res; 2013 Feb; 112(4):576-8. PubMed ID: 23410874
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment.
    La Rosa G; Biasucci LM; Mandolini C; Massimi I; Copponi G; Pulcinelli FM; Crea F
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):611-613. PubMed ID: 30015780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration.
    Jakubowski JA; Payne CD; Li YG; Brandt JT; Small DS; Farid NA; Salazar DE; Winters KJ
    Thromb Haemost; 2008 Feb; 99(2):409-15. PubMed ID: 18278193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.